Ziprasidone, a second-generation antipsychotic, affects core clock gene mRNA expression in mice

J Pharmacol Sci. 2020 Sep;144(1):57-59. doi: 10.1016/j.jphs.2020.06.005. Epub 2020 Jun 17.

Abstract

Some psychiatric diseases are associated with disruptions in the circadian clock system. Ziprasidone (ZIP), a second-generation antipsychotic, is widely used for psychiatry-related pharmacotherapy but its mechanism has not been clearly elucidated. We measured clock gene fluctuation patterns in the hippocampus and the amygdala in ZIP-treated mice. ZIP significantly increased Per1, Per2, and Bmal1 mRNA 2 h after the lights were turned off (ZT14) in the hippocampus, but not in the amygdala. These results suggest that ZIP might affect clock gene regulation, which could represent the pathway underlying symptom amelioration.

Keywords: Clock gene; Hippocampus; Ziprasidone.

MeSH terms

  • ARNTL Transcription Factors / genetics*
  • ARNTL Transcription Factors / metabolism*
  • Amygdala / metabolism
  • Animals
  • Antipsychotic Agents / pharmacology*
  • Biological Clocks / genetics*
  • Gene Expression / drug effects*
  • Gene Expression Regulation / drug effects*
  • Gene Expression Regulation / genetics*
  • Hippocampus / metabolism
  • Light
  • Male
  • Mice, Inbred C57BL
  • Period Circadian Proteins / genetics*
  • Period Circadian Proteins / metabolism*
  • Piperazines / pharmacology*
  • RNA, Messenger / genetics*
  • RNA, Messenger / metabolism*
  • Thiazoles / pharmacology*

Substances

  • ARNTL Transcription Factors
  • Antipsychotic Agents
  • Bmal1 protein, mouse
  • Per1 protein, mouse
  • Per2 protein, mouse
  • Period Circadian Proteins
  • Piperazines
  • RNA, Messenger
  • Thiazoles
  • ziprasidone